Title : A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegaly.

Pub. Date : 2009 Dec 1

PMID : 20003832






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: We show that, in escalating doses, pegvisomant results in age-adjusted normalization of IGF-I in nearly all such patients. pegvisomant insulin like growth factor 1 Homo sapiens
2 CONCLUSION: Our findings provide support for the long-term safety and efficacy of the GH receptor antagonist pegvisomant in achieving IGF-I control in patients with refractory acromegaly. pegvisomant insulin like growth factor 1 Homo sapiens